Report overview
This report contains market size and forecasts of Human Papillomavirus(HPV) Vaccines in global, including the following market information:
Global Human Papillomavirus(HPV) Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Papillomavirus(HPV) Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Papillomavirus(HPV) Vaccines companies in 2021 (%)
The global Human Papillomavirus(HPV) Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
2-Valent Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Papillomavirus(HPV) Vaccines include Merck, GSK and Walvax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Papillomavirus(HPV) Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Papillomavirus(HPV) Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Papillomavirus(HPV) Vaccines Market Segment Percentages, by Type, 2021 (%)
2-Valent Vaccine
4-Valent Vaccine
Global Human Papillomavirus(HPV) Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Papillomavirus(HPV) Vaccines Market Segment Percentages, by Application, 2021 (%)
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Global Human Papillomavirus(HPV) Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Papillomavirus(HPV) Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Papillomavirus(HPV) Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Papillomavirus(HPV) Vaccines revenues share in global market, 2021 (%)
Key companies Human Papillomavirus(HPV) Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Papillomavirus(HPV) Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Walvax
